Smith & Nephew PLC (SNN)
| Market Cap | 14.28B |
| Revenue (ttm) | 5.21B |
| Net Income (ttm) | 524.00M |
| Shares Out | 436.19M |
| EPS (ttm) | 1.19 |
| PE Ratio | 27.41 |
| Forward PE | 18.80 |
| Dividend | $0.74 (2.26%) |
| Ex-Dividend Date | Mar 31, 2022 |
| Volume | 397,605 |
| Open | 32.35 |
| Previous Close | 32.63 |
| Day's Range | 32.32 - 32.88 |
| 52-Week Range | 29.40 - 44.27 |
| Beta | 0.38 |
| Analysts | Buy |
| Price Target | 37.80 (+15.5%) |
| Earnings Date | Feb 24, 2022 |
About SNN
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform m...
Financial Performance
In 2021, Smith & Nephew's revenue was $5.21 billion, an increase of 14.30% compared to the previous year's $4.56 billion. Earnings were $524.00 million, an increase of 16.96%.
Financial StatementsAnalyst Forecast
According to 21 analysts, the average rating for SNN stock is "Buy." The 12-month stock price forecast is 37.8, which is an increase of 15.49% from the latest price.
News
Smith & Nephew Posts Q1 Sales Growth As Elective Procedures Rebound
Smith & Nephew PLC (NYSE: SNN) posted Q1 revenue of $1.31 billion, up 3.3% on a reported basis (including -2.6% currency effect) and up 5.9% on an underlying basis. Sports Medicine & ENT revenue up 8.6%...
Smith+Nephew announces new study showing GRAFIX™ Membrane cut the rate of diabetic foot ulcer recurrence in half comp...
LONDON , March 31, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces the publication of a peer-reviewed study in the Advances in Wound Care Journa...
Smith+Nephew to showcase latest Orthopaedic advancements in Cementless Knees, Total Hip Arthroplasty and Robotics at ...
LONDON , March 22, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces it will it showcase its latest innovations for Orthopaedic Reconstruction...
Smith+Nephew to feature Sports Medicine technology for joint repair and connected arthroscopic tower during AAOS 2022...
LONDON , March 21, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces it will showcase its latest Sports Medicine innovations for joint repair ...
Smith+Nephew embarks on the OXINIUM™ Technology Tour of Change; a mobile learning exhibit to showcase the best perfor...
LONDON, March 15, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces it has kicked-off the OXINIUM Technology Tour of Change mobile exhibit. ...
London Markets: Hargreaves Lansdown shares slump, while Smith & Nephew soar as U.K. stocks grapple with geopolitics
Surging commodity prices lifted London stocks to positive territory on Tuesday, as geopolitical tensions swirled around investors.
Smith+Nephew announces first surgery for its JOURNEY™ II Medial Dished System for total knee arthroplasty
LONDON, Feb. 10, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the first completed surgery using its JOURNEY II Medial Dished (MD) System ...
Smith+Nephew (SNN) to Acquire Orlando-Based Engage Surgical
Smith+Nephew's (SNN) acquisition of Engage Surgical reinforces its growth strategy while expanding its Orthopaedic Reconstruction product line.
Smith+Nephew expands next-generation handheld robotic-assisted CORI™ Surgical System into total hip arthroplasty with...
LONDON, Jan. 26, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the expansion of indications on its CORI Surgical System - the industry's m...
Smith+Nephew's PICO™ 7 and PICO 14 Negative Pressure Wound Therapy Systems are the first systems indicated to aid in ...
LONDON, Jan. 24, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce new indications for use for its PICO 7 and PICO 14 Single Use Negati...
Smith+Nephew acquires novel cementless partial knee system
LONDON, Jan. 19, 2022 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announces the acquisition of Engage Surgical, owner of the only cementless unicompartment...
Smith+Nephew (SNN) Introduces Real Intelligence & CORI System
Smith+Nephew (SNN) debuts new brand of enabling technology solutions as well as its next-generation handheld robotics platform in Canada.
Smith+Nephew (SNN) Rolls Out Robotic Assisted Surgical System
Smith+Nephew's (SNN) CORI system enables each patient to have a knee replacement that is shape-matched and aligned to their specific anatomy.
Smith+Nephew launches 'turn-key' robotic-assisted surgical system; designed to quickly augment the orthopaedic team's...
LONDON, Nov. 23, 2021 /PRNewswire/ -- Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, today announces the launch of CORI™ handheld robotics, an advanced system for both total an...
Smith+Nephew announces digital surgery and robotics innovation centre in Europe
LONDON, Nov. 16, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is proud to announce the creation of a purpose built digital surgery and robotics innovatio...
Smith+Nephew establishes its first Medical Education Centre for the Asia Pacific region in Singapore
State-of-the-art centre to focus on digital and robotic surgery LONDON, Nov. 9, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces its first de...
Smith+Nephew introduces the LEGION™ CONCELOC™ Cementless Total Knee System with proprietary 3D printed Advanced Porou...
LONDON, Nov. 2, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the introduction of its LEGION CONCELOC Cementless Total Knee System (TKS) a...
Smith+Nephew's IODOSORB™ Range shown more than twice as likely to heal wounds than standard care
LONDON, Oct. 26, 2021 /PRNewswire/ -- Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology business, is pleased to announce the results of a systematic review and meta-analysis of comparative ...
Smith+Nephew (SNN) Releases New Features for Hip Arthroplasty
Smith+Nephew (SNN) introduced the RI.HIP NAVIGATION software on the CORI Surgical System and announced the commercial availability of RI.INSIGHTS at the AAOS 2021 Annual Meeting.
Smith+Nephew introduces pioneering new technologies for its JOURNEY™ II total knee arthroplasty portfolio
LONDON , Sept. 1, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the introduction of two significant new technologies to its total knee art...
Smith+Nephew to expand Real Intelligence digital ecosystem and CORI™ Surgical System with total hip arthroplasty
LONDON , Sept. 1, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces significant enhancements to its Real Intelligence digital ecosystem and su...
Smith+Nephew launches new total ankle and total shoulder replacement technologies; showcases recently acquired Extrem...
LONDON, Aug. 31, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces it will feature its recently expanded Extremities portfolio at the American...
New data underscores material benefits of Smith+Nephew's OXINIUM™ DH Technology and OR3O™ Dual Mobility System for to...
LONDON, Aug. 31, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces it will showcase meaningful new material evidence for its OR3O Dual Mobilit...
Smith+Nephew to feature new Sports Medicine technology for joint repair and connected arthroscopic tower during AAOS ...
LONDON, Aug. 30, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces it will showcase its latest Sports Medicine innovations for joint repair an...
Smith+Nephew's OXINIUM™ Technology recognized as the best performing bearing with lowest risk of revision in total hi...
LONDON, Aug. 30, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces its proprietary OXINIUM (Oxidized Zirconium) Technology has established its...